click below
click below
Normal Size Small Size show me how
NURS 572 Pharm 56a
Pharm Diabetes Mellitus Drug drill only
| Question | Answer |
|---|---|
| regular insulin | quick/short insulin |
| lispro | quicker/shorter insulin |
| aspart | quicker/shorter insulin |
| glulisine | quicker/shorter insulin |
| NPH = neutral protamine hagedorn | intermediate insulin that can be mixed with quicker shorter and quick short (regular) |
| detemir | long acting insulin |
| glargine | super long insulin |
| glipizide, safe in elderly, renal impaired | sulfonylureas - secretagogue |
| glyburide | sulfonylureas - secretagogue |
| glimepiride | sulfonylureas - secretagogue |
| repaglinide | meglitinide - secretagogue |
| nateglinide | meglitinide - secretagogue |
| metformin | biguadide whose primary MOA is to decrease glycogenolysis. secondary MOA to increase receptor sensitivity. ADR lactic acidosis |
| pioglitazone | glitazone whose primary MOA is increased receptor sensitivity. secondary MOA is decreased glycogenolysis. ADR hepatotoxic |
| rosglitazone | glitazone whose primary MOA is increased receptor sensitivity. secondary MOA is decreased glycogenolysis. ADR hepatotoxic |
| acarbose | alpha-glucosidase inhibitor |
| miglitol | alpha-glucosidase inhibitor |
| pramlinitide | injectible amylin mimetic |
| exenatide BID | injectible incretin memetic |
| liraglutide QD | injectible incretin mimetic |
| sitagliptin oral QD | DPP4 inhibitor that potentiates incretin |
| saxagliptin oral QD | DPP4 inhibitor that potentiates incretin |
| linagliptin oral QD | DPP4 inhibitor that potentiates incretin |